Mark Anderson, MDCertificationsChair, Department of Cardiac Surgery University / Hospital AffiliationHackensack University Medical Center AboutDr. Anderson has extensive experience in cardiovascular care, including fellowship training in heart and lung transplantation. His clinical interests include the surgical management of heart failure and mechanical circulatory support, minimally invasive and robotic heart surgery as well as heart valve replacement and repair.
As a leading expert in mitral valve repair and replacements, Dr. Anderson is one of the highest volume mitral valve surgeons in the country where 95 percent of these surgeries use minimally invasive incisions, shortening two-month recoveries to just a few weeks.
|
Related Content
video Mark Anderson | Hackensack Meridian School of MedicineA New Strategy for the Treatment of Patients with Type 1 Cardiorenal Syndrome with Impella® – Presented at A‑CURE 2020. | video Dr. Mark Anderson, Hackensack University Medical CenterDr. Mark Anderson speaking the clinical experience and data of the novel right ventricular support device, Impella RP. | video Mark Anderson, MD, Einstein Healthcare NetworkCardiac Unloading and Myocardial Recovery: Clinical Utility from a Surgeon's Perspective |
Manuscripts & Publications
Treatment of Acute Myocardial Infarction and Cardiogenic Shock: Outcomes of the RECOVER III Postapproval Study by Society of Cardiovascular Angiography and Interventions Shock StageThe Society for Cardiovascular Angiography and Interventions proposed a staging system (A–E) to predict prognosis in cardiogenic shock. Herein, we report clinical outcomes of the RECOVER III study for the first time, according to Society for Cardiovascular Angiography and Interventions shock classification.
|
|
SHOCK5: Utilization of an RP Flex Impella to support Right Ventricular Dysfunction post Left Ventricular Assist Device PlacementRight ventricular dysfunction (RVD) during Left Ventricular Assist Device (LVAD) placement is associated with increased morbidity and mortality. Right Ventricular Assist Device (RVAD) implantation has been shown to reduce the severity of RVD and can improve overall outcomes.
|
|
Safety And Efficacy Of Impella RP Support For Acute Right Ventricular Failure Complicated By Cardiogenic Shock: Post Market Approval Sub-Analysis Of The CVAD RegistryThere is limited data on the use of Impella RP, a percutaneous right ventricular assist device (pRVAD) for hemodynamic support in acute right ventricular failure (RVF). This study aims to address this knowledge gap.
|